SEC Form D · filed April 5, 2021
Artiva Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Fred Aslan · San Diego, CAExec · DirectorEsther J. Van Den Boom · San Diego, CAExecBong J. Koh · San Diego, CADirectorYvonne J. Yamanaka · San Diego, CADirectorLaura J. Stoppel · San Diego, CADirectorJennifer J. Bush · San Diego, CAExecYong-Jun J. Huh · San Diego, CADirectorThomas J. Farrell · Houston, TXExecYu-Kyeong J. Hwang · San Diego, CADirectorJason J. Litten · San Diego, CAExecBrian J. Daniels · San Diego, CADirectorPeter J. Flynn · San Diego, CAExecLaura J. Stoppel · San Diego, CADirectorJennifer J. Bush · San Diego, CAExecYong-Jun J. Huh · San Diego, CADirectorThomas J. Farrell · San Diego, CAExecYu-Kyeong J. Hwang · San Diego, CADirectorFred Aslan · Sao Paulo, GuernseyExec · DirectorJason J. Litten · San Diego, CAExecEsther J. Van Den Boom · San Diego, CAExecBong J. Koh · San Diego, CADirectorBrian J. Daniels · San Diego, CADirectorPeter J. Flynn · San Diego, CAExecYvonne J. Yamanaka · San Diego, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗